Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: Prevalence and factors associated with adverse drug events among patients on dolutegravir-based regimen at the Immune Suppression Syndrome Clinic of Mbarara Regional Referral Hospital, Uganda: a mixed design study

Fig. 1

Commonly experienced ADEs by study participants on dolutegravir-based regimen at the ISS clinic-MRRH. ADE, adverse drug event; %, percentage (number of participants with ADE recorded/ total number of participants with at least one ADE recorded in their medical files)

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us